Atropine for pain after vitrectomy surgery
Part of Eyes & vision clinical trials.
This study tests whether atropine eye drops can reduce pain and prevent scar tissue (called posterior synechiae) after vitrectomy surgery. The goal is to see if this treatment helps you recover more comfortably.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are planning to have a vitrectomy (a type of eye surgery to remove the gel inside the eye).
- You are able to understand and agree to join the study.
- You will not be using any non-steroidal anti-inflammatory eye drops after surgery.
- Your doctor has not changed your usual eye drop plan to control swelling more than normal.
- You are not allergic to atropine or related medications.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if atropine 0.05% eye drops can slow down nearsightedness in children who have had cataract surgery and a lens implant. It is for children ages 1 to 7.
This trial compares different additives mixed with lidocaine (a numbing medicine) to improve how well the numbness works during eye surgery on the retina. The goal is to find the best combination to keep you comfortable during your procedure.
This study tests an eye drop called BL1332 to see if it can help reduce pain after photorefractive keratectomy (PRK), a type of laser eye surgery. If you are scheduled for PRK and are between 18 and 58 years old, you may be eligible.
This trial compares two pain medicines, Oliceridine and Oxycodone, given during eye surgery (vitrectomy) to see which works better and is safer. It may help patients who need pain control during the procedure.
This study tests if a medicine called gabapentin can safely reduce pain after a type of laser eye surgery called surface ablation. It's looking for adults with stable vision who are generally healthy and have not had previous eye procedures.
This study tests if using atropine eye drops in increasing doses can prevent nearsightedness (myopia) in children who are at risk. It is for children aged 6 to 9 who do not yet need glasses but have early signs of developing myopia.
Hear when a new Eye Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.